Male infertility
Conditions
Brief summary
Difference in sperm cell concentration (sperm cell concentration millions/mL) between the two groups, evaluted by the semen sample delivered at day 80
Detailed description
Difference in semen quality between the intervention group and the placebo group (total number of sperm cells, and total and percentage of motile, progressive motile and morphological normal sperm cells), evaluated by semen sample delivered at day 80 compared with baseline, Difference in spontaneous pregnancies before day 180, Difference in number of spontaneous abortions during the whole trial, Difference in serum levels of reproductive hormones (FSH, LH, AMH, Inhibin B) at day 80, Changes in serum levels of reproductive hormones (FSH, LH, AMH, Inhibin B) at day 80 within the groups
Interventions
Sponsors
Herlev Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 64 Years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in sperm cell concentration (sperm cell concentration millions/mL) between the two groups, evaluted by the semen sample delivered at day 80 | — |
Secondary
| Measure | Time frame |
|---|---|
| Difference in semen quality between the intervention group and the placebo group (total number of sperm cells, and total and percentage of motile, progressive motile and morphological normal sperm cells), evaluated by semen sample delivered at day 80 compared with baseline, Difference in spontaneous pregnancies before day 180, Difference in number of spontaneous abortions during the whole trial, Difference in serum levels of reproductive hormones (FSH, LH, AMH, Inhibin B) at day 80, Changes in serum levels of reproductive hormones (FSH, LH, AMH, Inhibin B) at day 80 within the groups | — |
Countries
Denmark
Outcome results
None listed